Editor's Picks
Editor's Picks
Primo Brands Upgraded to Buy by Jefferies on Growth and Valuation Appeal
March 27, 2026Upstream Bio Downgraded by Evercore on Lack of Near-Term Catalysts
March 27, 2026Evercore ISI downgraded Upstream Bio (NASDAQ: UPB) to In Line from Outperform and lowered its price target to $15 from $40, with shares falling more than 6% in pre-market trading...
Editor's Picks
We will not share your information & you can unsubscribe at any time. You agree to our terms of service & privacy policy. You agree to receive emails & correspondence from Nextmemealert.
